The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past, to children. A portion of the sharp increase in drugs used by…
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified. The FDA today said…
These are Thursday’s top ten analyst research summary upgrades, downgrades, and initiations from Wall Street brokerage firms: AstraZeneca (AZN) Cut to Hold at Citigroup. Brandywine Realty (BDN) Cut to Neutral at BofA/Merrill…
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a…
You can just see the TV advertisements now… Wal-Mart and Uncle Sam are “rolling back” swine flu. The retailer is in talks with federal officials about possibly putting vaccination sites in its…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones,…
These are the top 10 early bird analyst upgrades and downgrades we have seen in Wall Street research calls early this Thursday morning with over two hours until the market opens: AstraZeneca…
These are some of the top pre-market analyst upgrades we have seen from Wall Street early this Monday morning: AstraZeneca (AZN) Raised to Buy at UBS. BioMed Realty Trust (BMR) Raised to…
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual meeting, and…
These are some of the many pre-market downgrades and negative calls we have seen from Wall Street analysts this Friday morning:Allstate (ALL) Cut to Underweight at JPMorgan.AstraZeneca (AZN) Cut to Hold at…
These are some of the top pre-market analyst upgrades and positive calls we have seen on Wall Street this Friday morning: Accuray (ARAY) Raised to Buy at Piper Jaffray. AstraZeneca (AZN) Raised…
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red…
Last night was a novel release from the American Society of Clinical Oncology (or ASCO) as the society decided to publish all of the findings to the public at once. Keep in…
These aren’t the only impact analyst calls this morning, but these are the ones we are focusing the Tuesday in pre-market trading hours: Akamai Tech (NASDAQ: AKAM) Raised to Buy from Neutral…
